Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool

被引:21
|
作者
Crowell, Michael D. [1 ]
Umar, Sarah B. [1 ]
Lacy, Brian E. [2 ]
Jones, Michael P. [3 ]
DiBaise, John K. [1 ]
Talley, Nicholas J. [4 ]
机构
[1] Mayo Clin Arizona, Div Gastroenterol & Hepatol, Scottsdale, AZ 85259 USA
[2] Dartmouth Hitchcock Med Ctr, Gastroenterol & Hepatol, Lebanon, NH 03766 USA
[3] Henrico Doctors Hosp, Gastroenterol, Richmond, VA USA
[4] Univ Newcastle, Newcastle, NSW 2300, Australia
关键词
Gastrointestinal Symptoms Severity Index; Psychometrics; Gastrointestinal symptoms; Urogynecologic symptoms; Pelvic symptoms; IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL DYSPEPSIA; RISK-FACTORS; COMMUNITY; BURDEN; GASTROPARESIS; CONSTIPATION; PREVALENCE; DISORDERS; SUBGROUPS;
D O I
10.1007/s10620-015-3647-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Few instruments have been developed and validated for the evaluation of multi-dimensional GI symptoms. The Gastrointestinal Symptoms Severity Index (GISSI), a multi-dimensional, self-report instrument, was designed as a brief measure of the frequency, severity, and bothersomeness of individual GI and pelvic floor/urogynecologic symptoms. Aim To report the psychometric properties of the GISSI subscales, including factorial structure, validity, and internal consistency. Methods The GISSI included 32 items that assessed upper and lower GI symptoms and seven items related to pelvic floor/urogynecologic symptoms. A total of 934 patients presenting for upper and lower GI complaints completed the questionnaire between January 2013 and December 2013. The sample was randomly split into derivation (n=466) and validation datasets (n=468). A non-patient sample of 200 was collected separately. Results Exploratory factor analysis supported a six-factor model for the derivation sample that accounted for 69.3 % of the total variance. The six GI symptom clusters were labeled as constipation/difficult defecation (five items), abdominal pain/discomfort (four items), dyspepsia (four items), diarrhea/anal incontinence (four items), GERD/chest symptoms (four items), and nausea/vomiting (two items). Inclusion of additional items related to female pelvic floor/urogynecologic symptoms resulted in a separate factor. Confirmatory factor analysis of the validation dataset supported the a priori hypothesized six-factor measurement model (X-2(428)=1462.98; P<0.001; GFI=.88; RMSEA=.051). Conclusion The GISSI demonstrated good to excellent psychometric properties and provided multi-dimensional scaling of prominent GI symptom clusters. Further validation may provide an efficient, valid, and reliable measure of patient-reported clinical outcomes.
引用
收藏
页码:2270 / 2279
页数:10
相关论文
共 50 条
  • [31] Validation of the Meniere's disease patient-oriented symptom-severity index
    Gates, GA
    Verrall, AM
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (10) : 863 - 867
  • [32] The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale
    Labus, JS
    Bolus, R
    Chang, L
    Wiklund, I
    Naesdal, J
    Mayer, EA
    Naliboff, BD
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 89 - 97
  • [33] Validation of the Head and Neck Patient Symptom Checklist as a nutrition impact symptom assessment tool for head and neck cancer patients
    Schmidt, Karmen N.
    Olson, Kaerin
    Kubrak, Catherine
    Parliament, Matthew
    Ghosh, Sunita
    SUPPORTIVE CARE IN CANCER, 2013, 21 (01) : 27 - 34
  • [34] Validation of the Head and Neck Patient Symptom Checklist as a nutrition impact symptom assessment tool for head and neck cancer patients
    Karmen N. Schmidt
    Kärin Olson
    Catherine Kubrak
    Matthew Parliament
    Sunita Ghosh
    Supportive Care in Cancer, 2013, 21 : 27 - 34
  • [35] A brief multi-dimensional children's level-of-functioning tool
    Srebnik, D
    SYSTEM OF CARE FOR CHILDREN'S MENTAL HEALTH: EXPANDING THE RESEARCH BASE, ANNUAL RESEARCH CONFERENCE, PROCEEDINGS, 1997, : 445 - 452
  • [36] SEX AND BODY MASS INDEX HAVE DIFFERING RELATIONSHIPS WITH GASTROINTESTINAL SYMPTOM SEVERITY IN CHILDREN WITH GASTROPARESIS
    Febo-Rodriguez, Liz
    Chumpitazi, Bruno P.
    Musaad, Salma
    Sher, Andrew
    Shulman, Robert J.
    GASTROENTEROLOGY, 2020, 158 (06) : S624 - S624
  • [37] Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)
    Yost, KJ
    Yount, SE
    Eton, DT
    Silberman, C
    Broughton-Heyes, A
    Cella, D
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (03) : 295 - 298
  • [38] Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)
    Kathleen J. Yost
    Susan E. Yount
    David T. Eton
    Cheryl Silberman
    Anne Broughton-Heyes
    David Cella
    Breast Cancer Research and Treatment, 2005, 90 : 295 - 298
  • [39] A COMPARISON OF PATIENTS WITH UNEXPLAINED (FUNCTIONAL) SYMPTOMS OR ORGANIC GASTROINTESTINAL (GI) DISEASE: SYMPTOM SEVERITY, PSYCHIATRIC COMORBIDITIES, GASTROINTESTINAL DYSBIOSIS AND IMMUNE ACTIVIATION
    Shah, Ayesha
    Do, Anh
    Keely, Simon
    Walker, Marjorie M.
    Hansen, Teressa J.
    Rich, Justin
    Jones, Michael P.
    Koloski, Natasha A.
    Talley, Nicholas J.
    Morrison, Mark
    Holtmann, Gerald J.
    GASTROENTEROLOGY, 2019, 156 (06) : S1165 - S1165
  • [40] Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders
    Olariu, Elena
    Castro-Rodriguez, Jose-Ignacio
    Alvarez, Pilar
    Garnier, Carolina
    Reinoso, Marta
    Miguel Martin-Lopez, Luis
    Alonso, Jordi
    Forero, Carlos G.
    QUALITY OF LIFE RESEARCH, 2015, 24 (04) : 979 - 992